Trial Profile
Phase II trial of latrepidine in patients with mild-to-moderate Alzheimer's disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Latrepirdine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Medivation
- 05 Nov 2010 New trial record.